Wall Street analysts expect that CME Group Inc (NASDAQ:CME) will report sales of $910.75 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for CME Group’s earnings, with the highest sales estimate coming in at $940.70 million and the lowest estimate coming in at $889.00 million. CME Group reported sales of $912.90 million in the same quarter last year, which suggests a negative year over year growth rate of 0.2%. The business is scheduled to report its next quarterly earnings results before the market opens on Thursday, February 1st.

According to Zacks, analysts expect that CME Group will report full year sales of $910.75 million for the current year, with estimates ranging from $3.63 billion to $3.68 billion. For the next financial year, analysts expect that the business will post sales of $3.91 billion per share, with estimates ranging from $3.79 billion to $3.99 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that follow CME Group.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The business’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.05 earnings per share.

A number of brokerages have recently issued reports on CME. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a research note on Tuesday. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Royal Bank of Canada raised their price target on shares of CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $133.00 price objective on shares of CME Group in a report on Thursday, September 21st. Finally, Barclays raised their target price on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $144.22.

Shares of CME Group (CME) traded up $1.81 during midday trading on Wednesday, hitting $146.60. 322,110 shares of the stock traded hands, compared to its average volume of 1,480,000. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. CME Group has a one year low of $113.27 and a one year high of $155.29. The stock has a market cap of $49,890.00, a PE ratio of 33.24, a PEG ratio of 2.63 and a beta of 0.72.

The firm also recently declared a dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Thursday, December 28th will be given a dividend of $3.50 per share. This is a boost from CME Group’s previous dividend of $3.25. The ex-dividend date of this dividend is Wednesday, December 27th. CME Group’s payout ratio is currently 59.86%.

In other news, insider Jack J. Tobin sold 2,325 shares of the business’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $152.28, for a total value of $354,051.00. Following the sale, the insider now owns 17,574 shares of the company’s stock, valued at $2,676,168.72. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction on Wednesday, October 11th. The stock was sold at an average price of $136.83, for a total transaction of $342,075.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 38,953 shares of company stock valued at $5,642,851. Corporate insiders own 0.57% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. Fiduciary Trust Co. acquired a new stake in CME Group in the 2nd quarter valued at $105,000. Quadrant Capital Group LLC boosted its holdings in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after acquiring an additional 113 shares during the last quarter. Valeo Financial Advisors LLC bought a new stake in shares of CME Group during the 3rd quarter worth $124,000. San Francisco Sentry Investment Group CA bought a new stake in shares of CME Group during the 2nd quarter worth $129,000. Finally, People s United Financial Inc. raised its stake in shares of CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after purchasing an additional 110 shares during the period. Hedge funds and other institutional investors own 82.70% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “$910.75 Million in Sales Expected for CME Group Inc (CME) This Quarter” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/03/910-75-million-in-sales-expected-for-cme-group-inc-cme-this-quarter-2.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.